Related Experiment Videos
D-STAR: The Gemini Guardians redefining dual-targeting of immune cell therapy
1School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; Lingang Laboratory, Shanghai 200031, China.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
How soccer team students shape adolescent athlete engagement: evidence from an actor-partner interdependence model.
Frontiers in public health·2026
Hypereosinophilic syndrome with Löffler endocarditis and multiple cerebral infarctions in a patient with a CLL-phenotype clonal B-cell population: a case report.
Frontiers in cardiovascular medicine·2026
Subjective symptoms are associated with anxiety in patients with rosacea: a cross-sectional study.
Frontiers in public health·2026
Structured illumination microscopy for high SNR 3D imaging from millimeter-thick tissues to cellular dynamics.
Innovation (Cambridge (Mass.))·2026
Multiplexed genome editing by CRISPR-Un1Cas12f1 restores dystrophin expression in a mouse model of Duchenne muscular dystrophy.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
A phase 1/2 dose-escalation study of sepiapterin in patients with 6-pyruvoyl-tetrahydropterin synthase deficiency with hyperphenylalaninemia.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
D-Amino Acid Prodrug DLMEH Activates mTORC1 via Sestrin2 to Restore Muscle Protein Synthesis in Sarcopenia.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
Combination Of Bispecific Antibodies Enable Targeted TNFRSF Agonism and Effective Antitumor Activity.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
Protein-based masks to unlock conditional activation of therapeutics.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
Optimization of AsCas12f1-Mediated Long-Term Gene Repression.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
Predictors of high- versus low-intensity first-line multiple sclerosis treatments.
Multiple sclerosis journal - experimental, translational and clinical·2026
Optimizing rituximab dosing in multiple sclerosis: Real-world outcomes with interval extension.
Multiple sclerosis and related disorders·2026
Identification of core differentially expressed genes for respiratory syncytial virus infection.
Global medical genetics·2026
Case Report: Tirzepatide improves glycemic control in Rabson-Mendenhall syndrome.
Frontiers in endocrinology·2026
Sphingolipid Metabolism Links Morphological Signatures to Immunomodulatory Potency in Human Mesenchymal Stromal Cells.
Cellular and molecular bioengineering·2026